Cargando…

Baveno VII criteria for recompensation predict transplant-free survival in patients with hepatitis B-related decompensated cirrhosis

BACKGROUND & AIMS: The latest Baveno VII consensus has provided guidance for identifying patients who have truly recompensated from those with hepatic decompensation. This study aimed to evaluate patients’ transplant-free survival in three different stages of cirrhosis. METHODS: All patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hui, Vicki Wing-Ki, Wong, Grace Lai-Hung, Wong, Vincent Wai-Sun, Chan, Henry Lik-Yuen, Lai, Jimmy Che-To, Tse, Yee-Kit, Lai, Mandy Sze-Man, Yam, Tsz-Fai, Li, Dongrong, Fan, XiaoDan, Yip, Terry Cheuk-Fung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10400846/ https://www.ncbi.nlm.nih.gov/pubmed/37546279 http://dx.doi.org/10.1016/j.jhepr.2023.100814

Ejemplares similares

Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma
por: Wu, Claudia Wing-Kwan, et al.
Publicado: (2023)

Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria
por: Gao, Long, et al.
Publicado: (2023)

U-shaped relationship between urea level and hepatic decompensation in chronic liver diseases
por: Lin, Huapeng, et al.
Publicado: (2022)

Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients
por: Wong, Yu Jun, et al.
Publicado: (2023)

Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
por: Rodrigues, Susana G.
Publicado: (2023)

Recompensation of Decompensated Hepatitis B Cirrhosis: Current Status and Challenges
por: Zhao, Hong, et al.
Publicado: (2020)

Correspondence on Editorial regarding “Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients”
por: Wong, Yu Jun, et al.
Publicado: (2023)

Non-invasive tests-based risk stratification: Baveno VII and beyond
por: Semmler, Georg, et al.
Publicado: (2023)

The War’s Recompense
Publicado: (1918)

Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case–control study
por: Xu, Xiaomei, et al.
Publicado: (2021)

Was It an Adrenocortical Adenoma or an Adrenocortical Carcinoma? Limitation of the Weiss Scoring System in Determining the Malignant Potential of Adrenocortical Tumor: Report on Two Cases
por: Wong, Cheuk-Lik, et al.
Publicado: (2022)

The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
por: Yoo, Jeong-Ju, et al.
Publicado: (2023)

Intrarenal Doppler ultrasonography in patients with HFrEF and acute decompensated heart failure undergoing recompensation
por: Wallbach, M., et al.
Publicado: (2023)

Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2021)

Two different types of COVID-19 vaccines and serial liver biochemistries
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Three COVID-19 medications-remdesivir, molnupiravir and ritonavir-boosted nirmatrelvir-and serial liver biochemistries in 22, 456 subjects
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2020)

Clinical Outcomes Following Treatment for COVID-19 With Nirmatrelvir/Ritonavir and Molnupiravir Among Patients Living in Nursing Homes
por: Ma, Bosco Hon-Ming, et al.
Publicado: (2023)

Thyrotoxic Atrial Fibrillation: Factors Associated with Persistence and Risk of Ischemic Stroke
por: Wong, Cheuk-Lik, et al.
Publicado: (2017)

Colonoscopy and Risk of Colorectal Cancer in Patients With Nonalcoholic Fatty Liver Disease: A Retrospective Territory‐Wide Cohort Study
por: Zhang, Xinrong, et al.
Publicado: (2021)

Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
por: Hui, Vicki Wing-Ki, et al.
Publicado: (2020)

Serum fibrosis index-based risk score predicts hepatocellular carcinoma in untreated patients with chronic hepatitis B
por: Liang, Lilian Yan, et al.
Publicado: (2021)

Reply
por: Wong, Grace Lai-Hung, et al.
Publicado: (2023)

Association of metformin use on metabolic acidosis in diabetic patients with chronic hepatitis B‐related cirrhosis and renal impairment
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Novel machine learning models outperform risk scores in predicting hepatocellular carcinoma in patients with chronic viral hepatitis
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2022)

Application of Baveno Criteria and Modified Baveno Criteria with Shear-wave Elastography in Compensated Advanced Chronic Liver Disease
por: Kang, Seong Hee, et al.
Publicado: (2020)

Right ventricular temporal assist device for cardiac recompensation
por: Yan, Isabell, et al.
Publicado: (2017)

Concurrent primary hyperparathyroidism and pheochromocytoma in a Chinese lady with neurofibromatosis type 1
por: Wong, Cheuk-Lik, et al.
Publicado: (2018)

SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19
por: Wong, Grace Lai-Hung, et al.
Publicado: (2021)

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2021)

Alanine Aminotransferase Level: The Road to Normal in 2021
por: Yip, Terry Cheuk‐Fung, et al.
Publicado: (2021)

Pattern and impact of hepatic adverse events encountered during immune checkpoint inhibitors – A territory‐wide cohort study
por: Chan, Stephen Lam, et al.
Publicado: (2020)

Clinical features and prognosis of acute-on-chronic liver failure in patients with recompensated cirrhosis
por: Yuan, Haixia, et al.
Publicado: (2023)

Management of hepatitis B virus reactivation due to treatment of COVID-19
por: Yip, Terry Cheuk-Fung, et al.
Publicado: (2022)

Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers
por: Liang, Lilian Yan, et al.
Publicado: (2023)

Evaluation of Adverse Effects of Topical Glaucoma Medications on Trabeculectomy Outcomes Using the Glaucoma Medications Intensity Index
por: Wong, Jasper Ka Wai, et al.
Publicado: (2021)

Minimal Risk of Drug-Induced Liver Injury With Molnupiravir and Ritonavir-Boosted Nirmatrelvir
por: Wong, Grace Lai-Hung, et al.
Publicado: (2023)

Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment
por: Law, Man Fai, et al.
Publicado: (2017)

Validation and Refinement of the Baveno VI Criteria for Ruling Out High-Risk Varices
por: Zhou, Hong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d9i4opduf7iukict1s0ikgquv6